Lilly Eli Co stock is traded at $1,443.50, with a volume of 1,868,863. It is up +1.14% in the last 24 hours and up +23.75% over the past month. Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Previous Close:
$1,427.28
Open:
$1,429.91
24h Volume:
1,868,863
Relative Volume:
0.58
Market Cap:
$1.29T
Revenue:
$72.25B
Net Income/Loss:
$25.28B
P/E Ratio:
51.96
EPS:
$27.78
Net Cash Flow:
$10.37B
1W Performance:
+6.61%
1M Performance:
+23.75%
6M Performance:
+42.11%
1Y Performance:
+41.12%
1-Day Range:
$1,419.77$1,449.64
1-Week Range:
$1,364.58$1,460.00
52-Week Range:
$850.51$1,460.00
Lilly Eli Co Stock (LLY) Company Profile
Name
Lilly Eli CoSector
HealthcareIndustry
Drug Manufacturers - GeneralPhone
(317) 276-2000Address
LILLY CORPORATE CTR, INDIANAPOLIS, IN, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS